PATRIOTS!! This is your chance to participate in saving your country. This document dump was received from Pfizer by court order. It is the same documents that Pfizer wanted sealed for 75 years. Click the links for each document to browse thru their contents. On the right column are links for applying notations associated with a specific document. Once you complete a notation - it will be added to the database for review.


These documents are found at this website: https://phmpt.org/pfizers-documents/
It is the Pfizer document dump - released by court order. The docuents Pfizer wanted sealed for 75 years. All links connect directly to the PHMPT.org website, but also have a backup link for archiving purposes.
 DOWNLOAD THE FULL DOCUMENT ARCHIVE HERE

Dr Naomi Wolf discusses the Pfizer document dump that the big Pharma companies wanted sealed and hidden from public view for 75 YEARS!! In coordination with Steve Bannon and the Warroom Pandemic podcast listeners, Dr Wolf has organized an effort to get these documents scanned through with human eyes to highlight areas of interest and expose once and for all, what Pfizer and other perpetrators have been trying to hide from the public. Watch the videos below to understand what this project is about.

Access DailyClout.io to see the document campaigns where you can sign up and be part of this massive effort to bring down these criminals.
Main site: DailyClout.io |  Campaign Home - Pfizer Document Analysis: Daily Clout - Campaigns
Dr Naomi Wolf
Warroom - Saturday March 5, 2022
Dr Naomi Wolf
Warroom - Monday March 7, 2022
Dr Naomi Wolf
Warroom - Wednesday March 9, 2022

>>> PFIZER DOCUMENT DUMP LIST <<<
Doc IDFileNamePub DateNOTATIONS
15.2-listing-of-clinical-sites-and-cvs-pages-1-41.pdf  (Backup)2021-11-17NEW NOTATION
25.2-tabular-listing.pdf  (Backup)2021-11-17NEW NOTATION
35.3.6-postmarketing-experience.pdf  (Backup)2021-11-17VIEW / ADD
4BATES-92_adc19ef-ve-cov-7pd2-wo-eval-sas.txt  (Backup)2021-11-17NEW NOTATION
5BATES-93_tv.xpt  (Backup)2021-11-17NEW NOTATION
6BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txt  (Backup)2021-12-01NEW NOTATION
7BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txt  (Backup)2021-12-01NEW NOTATION
8BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txt  (Backup)2021-12-13NEW NOTATION
9BATES-FDA-CBER-2021-5683-0002375_addv-sas.txt  (Backup)2021-12-13NEW NOTATION
10BATES-FDA-CBER-2021-5683-0002376_relrec.xpt  (Backup)2021-12-13NEW NOTATION
11BATES-FDA-CBER-2021-5683-0002377_supppr.xpt  (Backup)2021-12-13NEW NOTATION
12BATES-FDA-CBER-2021-5683-0002378_ta.xpt  (Backup)2021-12-13NEW NOTATION
13BATES-FDA-CBER-2021-5683-0002379_te.xpt  (Backup)2021-12-13NEW NOTATION
14BATES-FDA-CBER-2021-5683-0002380_ti.xpt  (Backup)2021-12-13NEW NOTATION
15CRFs-for-site-1055.pdf  (Backup)2021-12-13NEW NOTATION
16Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-A.pdf  (Backup)2021-12-13NEW NOTATION
17Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-B.pdf  (Backup)2021-12-13NEW NOTATION
18STN-125742_0_0-Section-2.5-Clinical-Overview.pdf  (Backup)2021-12-13NEW NOTATION
19STN-125742_0_0-Section-2.7.3-Summary-of-Clinical-Efficacy.pdf  (Backup)2021-12-13NEW NOTATION
20STN-125742_0_0-Section-2.7.4-summary-clin-safety.pdf  (Backup)2021-12-13NEW NOTATION
21Supplemental-Index-12-22-21.pdf  (Backup)2021-12-13NEW NOTATION
22signed-F21-5683-CBER-Dec-13-2021-Response-Letter.pdf  (Backup)2021-12-22NEW NOTATION
23CRFs-for-site-1081.pdf  (Backup)2021-12-30NEW NOTATION
24CRFs-for-site-1096.pdf  (Backup)2022-01-18NEW NOTATION
25CRFs-for-site-1128.pdf  (Backup)2022-01-31NEW NOTATION
26125742_S1_M1_356h.pdf  (Backup)2022-03-01NEW NOTATION
27125742_S1_M1_3674.pdf  (Backup)2022-03-01NEW NOTATION
28125742_S1_M1_cover.pdf  (Backup)2022-03-01NEW NOTATION
29125742_S1_M1_debarment.pdf  (Backup)2022-03-01NEW NOTATION
30125742_S1_M1_exclusivity-claim.pdf  (Backup)2022-03-01NEW NOTATION
31125742_S1_M1_fast-track-designation.pdf  (Backup)2022-03-01NEW NOTATION
32125742_S1_M1_financial-cert-3454.pdf  (Backup)2022-03-01NEW NOTATION
33125742_S1_M1_financial-cert-bias.pdf  (Backup)2022-03-01NEW NOTATION
34125742_S1_M1_ipsp-agreed-letter.pdf  (Backup)2022-03-01NEW NOTATION
35125742_S1_M1_priority-review-request.pdf  (Backup)2022-03-01NEW NOTATION
36125742_S1_M1_trans-of-oblig.pdf  (Backup)2022-03-01NEW NOTATION
37125742_S1_M1_us-agent-authorization.pdf  (Backup)2022-03-01NEW NOTATION
38125742_S1_M1_userfee.pdf  (Backup)2022-03-01NEW NOTATION
39125742_S1_M1_waiver-req-designated-suffix.pdf  (Backup)2022-03-01NEW NOTATION
40125742_S1_M2_22_introduction.pdf  (Backup)2022-03-01NEW NOTATION
41125742_S1_M2_24_nonclinical-overview.pdf  (Backup)2022-03-01NEW NOTATION
42125742_S1_M2_26_pharmkin-tabulated-summary.pdf  (Backup)2022-03-01NEW NOTATION
43125742_S1_M2_26_pharmkin-written-summary.pdf  (Backup)2022-03-01NEW NOTATION
44125742_S1_M2_27_literature-references.pdf  (Backup)2022-03-01NEW NOTATION
45125742_S1_M2_27_synopses-indiv-studies.pdf  (Backup)2022-03-01NEW NOTATION
46125742_S1_M4_4223_185350.pdf  (Backup)2022-03-01NEW NOTATION
47125742_S1_M4_4223_R-20-0072.pdf  (Backup)2022-03-01NEW NOTATION
48125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdf  (Backup)2022-03-01NEW NOTATION
49125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdf  (Backup)2022-03-01NEW NOTATION
50125742_S1_M5_5351_c4591001-fa-interim-compliance.pdf  (Backup)2022-03-01NEW NOTATION
51125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdf  (Backup)2022-03-01NEW NOTATION
52125742_S1_M5_5351_c4591001-fa-interim-errata.pdf  (Backup)2022-03-01NEW NOTATION
53125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdf  (Backup)2022-03-01NEW NOTATION
54125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdf  (Backup)2022-03-01NEW NOTATION
55125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf  (Backup)2022-03-01NEW NOTATION
56125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf  (Backup)2022-03-01NEW NOTATION
57125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdf  (Backup)2022-03-01NEW NOTATION
58125742_S1_M5_5351_c4591001-fa-interim-protocol.pdf  (Backup)2022-03-01NEW NOTATION
59125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdf  (Backup)2022-03-01NEW NOTATION
60125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf  (Backup)2022-03-01NEW NOTATION
61125742_S1_M5_CRF_c4591001-1085-10851018.pdf  (Backup)2022-03-01NEW NOTATION
62125742_S1_M5_CRF_c4591001-1085-10851116.pdf  (Backup)2022-03-01NEW NOTATION
63125742_S1_M5_CRF_c4591001-1085-10851129.pdf  (Backup)2022-03-01NEW NOTATION
64125742_S1_M5_CRF_c4591001-1085-10851216.pdf  (Backup)2022-03-01NEW NOTATION
65125742_S1_M5_CRF_c4591001-1085-10851246.pdf  (Backup)2022-03-01NEW NOTATION
66125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdf  (Backup)2022-03-01NEW NOTATION
67125742_S1_M5_c4591001-A-adrg.pdf  (Backup)2022-03-01NEW NOTATION
68125742_S1_M5_c4591001-A-bmi-12-15-scale.pdf  (Backup)2022-03-01NEW NOTATION
69125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdf  (Backup)2022-03-01NEW NOTATION
70125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdf  (Backup)2022-03-01NEW NOTATION
71125742_S1_M5_c4591001-A-comorbidity-categories.pdf  (Backup)2022-03-01NEW NOTATION
72125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdf  (Backup)2022-03-01NEW NOTATION
73125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdf  (Backup)2022-03-01NEW NOTATION
74125742_S1_M5_c4591001-A-report-cci-aids-hiv.pdf  (Backup)2022-03-01NEW NOTATION
75125742_S1_M5_c4591001-A-report-cci-any-malignancy.pdf  (Backup)2022-03-01NEW NOTATION
76125742_S1_M5_c4591001-A-report-cci-cerebrovascular.pdf  (Backup)2022-03-01NEW NOTATION
77125742_S1_M5_c4591001-A-report-cci-chf.pdf  (Backup)2022-03-01NEW NOTATION
78125742_S1_M5_c4591001-A-report-cci-dementia.pdf  (Backup)2022-03-01NEW NOTATION
79125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.pdf  (Backup)2022-03-01NEW NOTATION
80125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.pdf  (Backup)2022-03-01NEW NOTATION
81125742_S1_M5_c4591001-A-report-cci-hemiplegia.pdf  (Backup)2022-03-01NEW NOTATION
82125742_S1_M5_c4591001-A-report-cci-leukemia.pdf  (Backup)2022-03-01NEW NOTATION
83125742_S1_M5_c4591001-A-report-cci-lymphoma.pdf  (Backup)2022-03-01NEW NOTATION
84125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.pdf  (Backup)2022-03-01NEW NOTATION
85125742_S1_M5_c4591001-A-report-cci-mi.pdf  (Backup)2022-03-01NEW NOTATION
86125742_S1_M5_c4591001-A-report-cci-mild-liver.pdf  (Backup)2022-03-01NEW NOTATION
87125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.pdf  (Backup)2022-03-01NEW NOTATION
88125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.pdf  (Backup)2022-03-01NEW NOTATION
89125742_S1_M5_c4591001-A-report-cci-periph-vasc.pdf  (Backup)2022-03-01NEW NOTATION
90125742_S1_M5_c4591001-A-report-cci-pulmonary.pdf  (Backup)2022-03-01NEW NOTATION
91125742_S1_M5_c4591001-A-report-cci-renal.pdf  (Backup)2022-03-01NEW NOTATION
92125742_S1_M5_c4591001-A-report-cci-rheumatic.pdf  (Backup)2022-03-01NEW NOTATION
93125742_S1_M5_c4591001-T-S-final-reacto-tables-track.pdf  (Backup)2022-03-01NEW NOTATION
94125742_S1_M5_c4591001-T-S-roadmap.pdf  (Backup)2022-03-01NEW NOTATION
95125742_S1_M5_c4591001-T-S-summary-differences-csr-vs-update.pdf  (Backup)2022-03-01NEW NOTATION
96125742_S1_M5_c4591001-T-S-suppl-arg.pdf  (Backup)2022-03-01NEW NOTATION
97125742_S1_M5_c4591001-T-S-updated-reacto-tlf.pdf  (Backup)2022-03-01NEW NOTATION
98FDA-CBER-2021-5683-0021888-to-0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txt  (Backup)2022-03-01NEW NOTATION
99FDA-CBER-2021-5683-0021902-to-0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sas.txt  (Backup)2022-03-01NEW NOTATION
100FDA-CBER-2021-5683-0021916-to-0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sas.txt  (Backup)2022-03-01NEW NOTATION
101FDA-CBER-2021-5683-0021930-to-0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sas.txt  (Backup)2022-03-01NEW NOTATION
102FDA-CBER-2021-5683-0021944-to-0021963_125742_S1_M5_c4591001-A-P-adae-sas.txt  (Backup)2022-03-01NEW NOTATION
103FDA-CBER-2021-5683-0021964-to-0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sas.txt  (Backup)2022-03-01NEW NOTATION
104FDA-CBER-2021-5683-0021981-to-0022027_125742_S1_M5_c4591001-A-P-adc19ef-sas.txt  (Backup)2022-03-01NEW NOTATION
105FDA-CBER-2021-5683-0022028-to-0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sas.txt  (Backup)2022-03-01NEW NOTATION
106FDA-CBER-2021-5683-0022041-to-0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt  (Backup)2022-03-01NEW NOTATION
107FDA-CBER-2021-5683-0022054-to-0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txt  (Backup)2022-03-01NEW NOTATION
108FDA-CBER-2021-5683-0022063-to-0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txt  (Backup)2022-03-01NEW NOTATION
109FDA-CBER-2021-5683-0022136-to-0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txt  (Backup)2022-03-01NEW NOTATION
110FDA-CBER-2021-5683-0022326-to-0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txt  (Backup)2022-03-01NEW NOTATION
111FDA-CBER-2021-5683-0022346-to-0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txt  (Backup)2022-03-01NEW NOTATION
112FDA-CBER-2021-5683-0022365-to-0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txt  (Backup)2022-03-01NEW NOTATION
113FDA-CBER-2021-5683-0022561-to-0022567_125742_S1_M5_c4591001-A-P-adds-sas.txt  (Backup)2022-03-01NEW NOTATION
114FDA-CBER-2021-5683-0022568-to-0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txt  (Backup)2022-03-01NEW NOTATION
115FDA-CBER-2021-5683-0022601-to-0022617_125742_S1_M5_c4591001-A-P-admh-sas.txt  (Backup)2022-03-01NEW NOTATION
116FDA-CBER-2021-5683-0022618-to-0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txt  (Backup)2022-03-01NEW NOTATION
117FDA-CBER-2021-5683-0022692-to-0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txt  (Backup)2022-03-01NEW NOTATION
118FDA-CBER-2021-5683-0022766-to-0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txt  (Backup)2022-03-01NEW NOTATION
119FDA-CBER-2021-5683-0022793-to-0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txt  (Backup)2022-03-01NEW NOTATION
120FDA-CBER-2021-5683-0022867-to-0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txt  (Backup)2022-03-01NEW NOTATION
121FDA-CBER-2021-5683-0023007-to-0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txt  (Backup)2022-03-01NEW NOTATION
122FDA-CBER-2021-5683-0023032-to-0023065_125742_S1_M5_c4591001-A-P-adva-sas.txt  (Backup)2022-03-01NEW NOTATION
123FDA-CBER-2021-5683-0023455-to-0023486_125742_S1_M5_c4591001-A-define-2-0-0.xsl  (Backup)2022-03-01NEW NOTATION
124FDA-CBER-2021-5683-0023490-to-0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale-1.xlsx  (Backup)2022-03-01NEW NOTATION
125FDA-CBER-2021-5683-0023490-to-0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsx  (Backup)2022-03-01NEW NOTATION
126FDA-CBER-2021-5683-0023500-to-0023507_125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.xlsx  (Backup)2022-03-01NEW NOTATION
127FDA-CBER-2021-5683-0023523-to-0023538_125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.xlsx  (Backup)2022-03-01NEW NOTATION
128FDA-CBER-2021-5683-0023540_125742_S1_M5_c4591001-A-comorbidity-categories.xlsx  (Backup)2022-03-01NEW NOTATION
129FDA-CBER-2021-5683-0023550-to-0023569_125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.xlsx  (Backup)2022-03-01NEW NOTATION
130FDA-CBER-2021-5683-0023711-to-0023875_125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.xlsx  (Backup)2022-03-01NEW NOTATION
131FDA-CBER-2021-5683-0023878_125742_S1_M5_c4591001-A-report-cci-aids-hiv.xlsx  (Backup)2022-03-01NEW NOTATION
132FDA-CBER-2021-5683-0023895-to-0023915_125742_S1_M5_c4591001-A-report-cci-any-malignancy.xlsx  (Backup)2022-03-01NEW NOTATION
133FDA-CBER-2021-5683-0023919-to-0023921_125742_S1_M5_c4591001-A-report-cci-cerebrovascular.xlsx  (Backup)2022-03-01NEW NOTATION
134FDA-CBER-2021-5683-0023924_125742_S1_M5_c4591001-A-report-cci-chf.xlsx  (Backup)2022-03-01NEW NOTATION
135FDA-CBER-2021-5683-0023926_125742_S1_M5_c4591001-A-report-cci-dementia.xlsx  (Backup)2022-03-01NEW NOTATION
136FDA-CBER-2021-5683-0023928_125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.xlsx  (Backup)2022-03-01NEW NOTATION
137FDA-CBER-2021-5683-0023930_125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.xlsx  (Backup)2022-03-01NEW NOTATION
138FDA-CBER-2021-5683-0023932_125742_S1_M5_c4591001-A-report-cci-hemiplegia.xlsx  (Backup)2022-03-01NEW NOTATION
139FDA-CBER-2021-5683-0023936-to-0023937_125742_S1_M5_c4591001-A-report-cci-leukemia.xlsx  (Backup)2022-03-01NEW NOTATION
140FDA-CBER-2021-5683-0023944-to-0023950_125742_S1_M5_c4591001-A-report-cci-lymphoma.xlsx  (Backup)2022-03-01NEW NOTATION
141FDA-CBER-2021-5683-0023955-to-0023958_125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.xlsx  (Backup)2022-03-01NEW NOTATION
142FDA-CBER-2021-5683-0023960_125742_S1_M5_c4591001-A-report-cci-mi.xlsx  (Backup)2022-03-01NEW NOTATION
143FDA-CBER-2021-5683-0023963_125742_S1_M5_c4591001-A-report-cci-mild-liver.xlsx  (Backup)2022-03-01NEW NOTATION
144FDA-CBER-2021-5683-0023965_125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.xlsx  (Backup)2022-03-01NEW NOTATION
145FDA-CBER-2021-5683-0023967_125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.xlsx  (Backup)2022-03-01NEW NOTATION
146FDA-CBER-2021-5683-0023971-to-0023972_125742_S1_M5_c4591001-A-report-cci-periph-vasc.xlsx  (Backup)2022-03-01NEW NOTATION
147FDA-CBER-2021-5683-0023975-to-0023976_125742_S1_M5_c4591001-A-report-cci-pulmonary.xlsx  (Backup)2022-03-01NEW NOTATION
148FDA-CBER-2021-5683-0023979-to-0023980_125742_S1_M5_c4591001-A-report-cci-renal.xlsx  (Backup)2022-03-01NEW NOTATION
149FDA-CBER-2021-5683-0023983-to-0023984_125742_S1_M5_c4591001-A-report-cci-rheumatic.xlsx  (Backup)2022-03-01NEW NOTATION
150FDA-CBER-2021-5683-0023987_125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.xlsx  (Backup)2022-03-01NEW NOTATION